Inventor · disambiguated record
Lars Frelin
Also filed as: FRELIN LARS
8 granted patents·18 pending applications·56 citations·filing 2005–2022
86Inventor score
Files withCHRONTECH PHARMA AB10SVENSKA VACCINFABRIKEN PRODUKTION AB6SALLBERG MATTI3SAELLBERG MATTI2TRIPEP AB2
Top patents by PatentIndex Score
26 records- 0193US8445663B2Compositions and methods that enhance an immune responseSAELLBERG MATTI·Filed 2010·Granted May 21, 2013·17 cites·18 claims
- 0290US8258275B2Immunogen platformSAELLBERG MATTI·Filed 2011·Granted Sep 4, 2012·12 cites·16 claims
- 0390US8071561B2Immunogen platformSALLBERG MATTI·Filed 2008·Granted Dec 6, 2011·10 cites·8 claims
- 0482US7566812B2Transgenic mouse models of hepatitis C virus (HCV) and identification of HCV therapeuticsTRIPEP AB·Filed 2005·Granted Jul 28, 2009·4 cites·13 claims
- 0581US8883169B2Immunogen platformSäLLBERG MATTI·Filed 2011·Granted Nov 11, 2014·4 cites·18 claims
- 0676US10905760B2Chimeric hepatitis D virus antigen and hepatitis B virus pre S1 genes for use alone or in vaccines containing hepatitis B virus genesSVENSKA VACCINFABRIKEN PRODUKTION AB·Filed 2017·Granted Feb 2, 2021·1 cites·24 claims
- 0774US9457183B2Injection needle and deviceSALLBERG MATTI·Filed 2012·Granted Oct 4, 2016·8 cites·17 claims
- 0869US2015051388A1Immunogen platformCHRONTECH PHARMA AB·Filed 2014·Application pending·0 cites
- 0964US11478544B2Chimeric hepatitis D virus antigen and hepatitis B virus pre S1 genes for use alone or in vaccines contaning hepatitis B virus genesSVENSKA VACCINFABRIKEN PRODUKTION AB·Filed 2020·Granted Oct 25, 2022·0 cites·14 claims
- 1061US2025197452A1Compositions and methods for treating and preventing hepatitis b and dSVF VACCINES AB·Filed 2022·Application pending·0 cites
- 1159US2009214593A1Immunogen platformTRIPEP AB·Filed 2009·Application pending·0 cites
- 1258US2013202554A1Compositions and methods that enhance an immune responseCHRONTECH PHARMA AB·Filed 2013·Application pending·0 cites
- 1358US2017058003A1Immunogen platformCHRONTECH PHARMA AB·Filed 2016·Application pending·0 cites
- 1458US2023295244A1Compositions and methods for treating and preventing coronavirusesSVENSKA VACCINFABRIKEN PRODUKTION AB·Filed 2022·Application pending·0 cites
- 1556US2014286985A1Simple vaccines from dna launched suicidal flavivirusesCHRONTECH PHARMA AB·Filed 2014·Application pending·0 cites
- 1655US2015252084A1Compositions and methods that enhance an immune responseCHRONTECH PHARMA AB·Filed 2015·Application pending·0 cites
- 1753US2023079898A1Compositions and methods for treating and preventing hepatitis b and dSVENSKA VACCINFABRIKEN PRODUKTION AB·Filed 2021·Application pending·0 cites
- 1851US2023330211A1Compositions and methods for treating and preventing coronavirusesSVENSKA VACCINFABRIKEN PRODUKTION AB·Filed 2021·Application pending·0 cites
- 1951US2016228531A1Treatment of hepatitis d virus infections by redirection of t cellsCHRONTECH PHARMA AB·Filed 2014·Application pending·0 cites
- 2050US2012027795A1Simple vaccines from dna launched suicidal flavivirusesSALLBERG MATTI·Filed 2011·Application pending·0 cites
- 2148US2016215023A1Simple vaccines from dna launched suicidal flavivirusesChonTech Pharma AB·Filed 2015·Application pending·0 cites
- 2247US2016235928A1Injection needle and deviceCHRONTECH PHARMA AB·Filed 2016·Application pending·0 cites
- 2347US2016324954A1Immunogenic compositions for inhibiting hepatitis d virusCHRONTECH PHARMA AB·Filed 2014·Application pending·0 cites
- 2446US2017216573A1Injection needle and deviceCHRONTECH PHARMA AB·Filed 2016·Application pending·0 cites
- 2545US2022152108A1Chimeric antigen receptors directed to cells expressing the sodium taurocholate co-transporting receptorSVENSKA VACCINFABRIKEN PRODUKTION AB·Filed 2020·Application pending·0 cites
- 2644US2013012865A1Codon-optimzed hepatitis b virus core antigen (hbcag)CHRONTECH PHARMA AB·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →